Culturally Tailored Messages Increase HPV Vaccination of Asian American Adolescents

Results from a pilot study supported by the National Cancer Institute’s Center to Reduce Cancer Health Disparities and presented at the 11th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held November 2-5, 2018 in the Sheraton New Orleans Hotel, New Orleans, Louisiana, USA, showed the effects of specifically designed culturally...

Cultural Competency Training Improves Oncologists’ LGBT-related Knowledge and Clinical Practices

An interactive online LGBT cultural competency training program for oncologists may be improve LGBT-related knowledge and clinical practices. This is the preliminary result of a pilot study of oncologists in Florida, supported by a grant from the Florida Academic Cancer Center Alliance, which was presented at the 11th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic...

Study Shows Hormonal Breast Cancer Therapies Increased in States that Expanded Medicaid

An evaluation of breast cancer patients enrolled in Medicaid showed that states that expanded Medicaid during 2011 to 2017 had a 27% increase in prescriptions for hormonal therapy medications compared to states that did not expand Medicaid during the same period. These results of a study funded by the American Cancer Society were presented at the 11th AACR Conference on...

Predicting Survival in African-American Women with Breast Cancer: A New Prognostic Model May Help

A study funded by grants from the National Cancer Institute and the National Institutes of Health and presented at the 11th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held November 2-5, 2018 in the Sheraton New Orleans Hotel, New Orleans, Louisiana, USA, explains how a prognostic model developed using a...

How to Better Utilize the Immune System – Neoadjuvant Therapy to Help Downstage Tumors

It's a question that begs being answered: Can physicians use immunotherapy more effectively? The answer may be a simple 'Yes.' In the treatment of a number of cancers, immunotherapy is already the standard of care and clinical trials are ongoing for many others. This is especially the case in the treatment of patients with late stage disease. A widely used form of...

Study Confirms Local Radiotherapy to Improve Survival in Metastatic Prostate Cancer

According to recent data from the American Cancer Society, about 1 in 9 men will be diagnosed with prostate cancer during his lifetime and about 6 in 10 are diagnosed at aged 65 or older. Between 1990 and 2015, the incident of of prostate cancer increased 3.7-fold. In 2018 the United States about 164,690 men are diagnosed with a...

Addition of Pelvic Lymph Node Radiation may Significant Improve Prostate Cancer Treatment

Initial reports from a large international clinical trial suggest that, in the treatment of man with prostate cancer that recurs after prostatectomy, the surgical removal of the prostate gland, extending radiation therapy to the pelvic lymph nodes combined with adding short-term hormone therapy to standard treatment can extend the amount of time before their cancer spreads. These findings, presented at...

Cetuximab Causes Less Side Effects and May be a Good Treatment Option for HPV+ Throat Cancer

Over the last decades human papilloma virus (HPV-) positive throat cancer incidence is rapidly increasing worldwide while the incidence of head and neck squamous cancers overall has declined in developed countries. The incidence of throat cancer is rapidly becoming more common in Western countries. For example in the United Kingdom, incidence was unchanged in 1970 to 1995, then doubled in...

Study Shows Zoledronic Acid Improves Disease-free Survival in Premenopausal HR+ early Breast Cancer

Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival compared to tamoxifen in premenopausal women with hormone receptor positive (HR+) early breast cancer. This is the conclusion of a study presented at European Society for Medical Oncology - ESMO 2018 Congress in Munich, Germany. It is the first...

Pembrolizumab Improves Survival of Patients with Metastatic or Recurrent Head and Neck Cancer

Late-breaking results from the KEYNOTE-048 study (NCT02358031) reported at the annual congress of the European Society for Medical Oncology - ESMO 2018, in Munich, Germany, show that immunotherapy with pembrolizumab (Keytruda®; Merck Sharp & Dohme, a subsidiary of Merck & Co), a humanized IgG4 isotype antibody targeting the programmed cell death 1 receptor (also known as PD-1 and CD279)...

right side

ads

Related articles